Progression of alternating hemiplegia of childhood-related focal epilepsy to electrical status epilepticus in sleep with reversible encephalopathy.


Journal

Epileptic disorders : international epilepsy journal with videotape
ISSN: 1950-6945
Titre abrégé: Epileptic Disord
Pays: United States
ID NLM: 100891853

Informations de publication

Date de publication:
01 Feb 2022
Historique:
pubmed: 19 11 2021
medline: 29 3 2022
entrez: 18 11 2021
Statut: ppublish

Résumé

Mutations in the ATP1A3 gene (which encodes the main α subunit in neuronal Na+/K+-ATPases) cause various neurological syndromes including alternating hemiplegia of childhood. This rare disorder is characterized by paroxysmal episodes of hemiplegia, dystonia, oculomotor abnormalities, and occasionally developmental regression. Approximately 50% of alternating hemiplegia of childhood patients also have epilepsy, which is either focal or generalized. Seizures are often drug resistant. We report a 10-year-old girl with the D801N ATP1A3 mutation and alternating hemiplegia of childhood who manifested with drug-resistant focal seizures as an infant and throughout childhood. At the age of about10.5 years, her epilepsy evolved into electrical status epilepticus in sleep with generalized discharges. These changes coincided with developmental regression consistent with epileptic encephalopathy. Additionally, MRI and MR spectroscopy showed new cortical atrophy and markedly depressed N-acetyl aspartate peaks compared to previous normal studies. Electrical status epilepticus in sleep resolved after medication adjustments. She, now, only four months after her diagnosis of electrical status epilepticus in sleep, has regained most of the skills that were lost only a few months earlier. Our observations document that alternating hemiplegia of childhood can result in the above-described unique features; particularly, progression of focal epilepsy to electrical status epilepticus in sleep with generalized features and reversible epileptic encephalopathy.

Identifiants

pubmed: 34789444
pii: epd.2021.1377
doi: 10.1684/epd.2021.1377
doi:

Substances chimiques

ATP1A3 protein, human 0
Sodium-Potassium-Exchanging ATPase EC 7.2.2.13

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

183-190

Auteurs

Derek Neupert (D)

Department of Neurology at Duke University School of Medicine, Durham, North Carolina, USA.

Puya Abbassi (P)

Department of Neurology at Duke University School of Medicine, Durham, North Carolina, USA.

Lyndsey Prange (L)

Division of Pediatric Neurology, Department of Pediatrics at Duke University School of Medicine, Durham, North Carolina, USA.

Robert Flamini (R)

PANDA Neurology & Atlanta Headache Specialist, Atlanta, Georgia, USA.

Mohamad A Mikati (MA)

Division of Pediatric Neurology, Department of Pediatrics at Duke University School of Medicine, Durham, North Carolina, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH